This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Knowing what to include in retirement planning is crucial for a solid financial strategy. Explore essential elements to consider for your future.
17,452 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...
Investors are watching PLBY closely as plby (plby) 2026 earnings unfold. This article breaks down Q1 results, evaluat...
MSGM's Q1 2026 commentary offers a clearer view of the year ahead for investors. This article decodes the msgm 2026 e...
Global markets slide as diplomatic talks stall and tensions rise around the Strait of Hormuz, driving a broad sell-of...
Patience and big-capital bets define Iren's path. This analysis explains why Iren's earnings highlight long-term grow...
SpaceX IPO chatter has investors itching for early exposure. This guide breaks down the smartest, legally sound ways ...
A leading hedge fund shocks markets with a major pivot into AI infrastructure, prioritizing hardware, energy-ready da...
Hive Digital Technologies stock surged this week thanks to a major AI infrastructure project from its subsidiary. Thi...
As earnings season arrives, smart investors are drilling into Transcat's 2026 earnings outlook. This guide breaks dow...
Florida’s housing market finds footing in late May 2026 as pending sales rise and inventory stabilizes. Sellers face ...
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...